Our vision for the Department of Obstetrics, Gynecology and Reproductive Biology at the Michigan State University College of Human Medicine is to be the leader in the clinical translation of cutting edge research to the patients and communities that we serve. We are focused on ensuring that our research is translated to the health care needs of women across their life spans and in diverse communities. Our faculty members have achieved national recognition for this research. Since 2009, our department has ranked in the top 23 of 135 departments of obstetrics and gynecology across the country in National Institutes of Health funding for research. We have recruited accomplished researchers in women’s health, including physicians, nurses, sociologists, clinical translational scientists and epidemiologists focused not only on the medical aspects, but on the social disparities that threaten women’s health. Collaborating with each other and with our health care partners, we are:
- Unraveling the causes and pursuing better treatments for infertility.
- Seeking better therapies for endometriosis, a painful condition that afflicts as many as 1 in 10 women of reproductive age.
- Studying the connection between endometriosis and endometrial and ovarian cancers and looking for possible genetic targets for treatment.
- Identifying the mechanisms that cause uterine and ovarian cancer.
- Researching inflammation as a cause of premature births and developing ways to prevent it.
- Examining the health implications of assisted reproductive technology, including whether it is associated with birth defects and later health problems in children and their mothers.
- Leveraging the resources of other health care agencies and community groups to give Medicaid beneficiaries the best prenatal care in the most cost-effective way, thus helping assure that they and their babies will be healthy.
- Working within families to erase health disparities and raise awareness among African-American, Latino and Arab women about the importance of screening and prevention of breast and cervical cancers.
Our research programs rest on three departmental pillars, which include supporting unparalleled health services to women at home and nationally, educating exemplary physicians and scholars, and discovering and disseminating innovative medical knowledge. We look forward to sharing with you the various departmental programs and the impact they have on the everyday lives of women.
Richard E. Leach, M.D., FACOG, FACS
Professor and Chair
Department of Obstetrics, Gynecology and Reproductive Biology
Tuesday, April 26 7:00 P.M.
The importance of comprehensive and timely prenatal care has been known for many years, yet in the United States, only 7 in 10 pregnant women receive adequate prenatal care. Inadequate care is not only detrimental to the mother, but can lead to complications for the baby that could impact their adult life. Join Dr. Richard Leach at this Your Health Lecture to learn about the startling science that supports the fetal determinants of adult disease, Tuesday, April 26, at 7 p.m., at Providence-Providence Park, Novi.
The Your Health Lecture Series is a collaborative community event sponsored by Providence-Providence Park, Novi and Michigan State University College of Human Medicine Flint Campus.
FREE COMMUNITY EVENT
RSVP requested at CHM Website or 616.234.2667
We would like to congratulate Mike Strug for the successful defense of his PhD thesis entitled “RBPJ mediates top Notch postpartum repair for future pregnancy potential and is reduced in recurrent pregnancy loss (RPL)”. Dr. Asgi Fazleabas was Mike’s graduate advisor and supported a F30 National Research Service Award from the National Institute of Child Health and Human Development. Mike recently received the Society for Reproductive Investigation Pfizer-President’s Presenter’s Award to be award at this year’s meeting in Montreal. Following his PhD studies, Mike will now resume his third and fourth year medical school education in clinical clerkships.
When Asgi Fazleabas came to MSU College of Human Medicine in 2009, the Center for Women’s Health was only a dream. No building. A small staff of researchers. But what began with a vision has grown exponentially.
“We have far exceeded what I ever dreamed of,” Fazleabas said. “With the expansion of the medical school in Grand Rapids, the vision we had, the ability to recruit the brightest from Harvard, Yale and Baylor…we realized the excitement of building an outstanding research program.”
While studying cervical cancer statistics compiled by the US Centers for Disease Control and Prevention, Dr. Sabrina Ford noticed a discrepancy she thought must be a mistake. While African American women undergo screenings for cervical cancer at a higher rate than white women, they die from the disease at almost twice the rate.
The American Cancer Society indicates that ovarian cancer is the fifth most lethal of all cancers that specifically affect women. They estimate that in 2014 approximately 22,000 women will be diagnosed with ovarian cancer and about 14,000 will die of this disease. This high death rate has not changed much since the 1960s. We are therefore very interested in uncovering new ways to reverse this poor patient outcome.
To contribute to For The Love of a Woman Discovery Fund, which supports new discoveries in Gynecological cancer, reproductive health and maternal infant health GO TO OUR FORM. For more information please contact the Advancement Office at 1-855-678-7444.